XML 91 R79.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income (loss) including non-controlling interests $ (107,978) $ 3,712
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:    
Equity in earnings (loss) of subsidiaries 0 0
Depreciation, depletion and amortization 189,833 149,265
Loss on sale of properties 2,922 0
Impairment 629 93
Deferred income taxes (3,547) 828
Derivative instruments 117,611 71,116
Equity-based compensation expenses 9,013 6,754
Deferred financing costs amortization and other 6,930 5,475
Working capital and other changes:    
Change in accounts receivable, net (71,083) (5,708)
Change in inventory (3,184) (3,672)
Change in prepaid expenses 1,505 492
Change in accounts payable, interest payable and accrued liabilities 36,666 (244)
Change in other assets and liabilities, net (4,391) 248
Net cash provided by operating activities 174,926 228,359
Cash flows from investing activities:    
Capital expenditures (237,448) (254,838)
Acquisitions 0 (520,728)
Derivative settlements 13,446  
Derivative settlements   (36,974)
Other 0 (28)
Net cash used in investing activities (224,002) (812,568)
Cash flows from financing activities:    
Proceeds from Revolving Credit Facilities 420,000 1,470,000
Principal payments on revolving credit facility (368,000) (875,000)
Deferred financing costs (43) (215)
Purchases of treasury stock (4,261) (6,021)
Distributions to non-controlling interests (4,937) (3,450)
Investment in / capital contributions from subsidiaries 0 0
Other (431) (90)
Net cash provided by financing activities 42,328 585,224
Increase (decrease) in cash and cash equivalents (6,748) 1,015
Beginning of period 22,190 16,720
End of period 15,442 17,735
Intercompany Eliminations    
Cash flows from operating activities:    
Net income (loss) including non-controlling interests 44,453 (65,442)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:    
Equity in earnings (loss) of subsidiaries (46,153) 63,693
Depreciation, depletion and amortization (5,165) (3,326)
Loss on sale of properties 0  
Impairment 0 0
Deferred income taxes 0 0
Derivative instruments 0 0
Equity-based compensation expenses 0 0
Deferred financing costs amortization and other 0 0
Working capital and other changes:    
Change in accounts receivable, net (42,831) (70,526)
Change in inventory 0 0
Change in prepaid expenses 0 0
Change in accounts payable, interest payable and accrued liabilities 42,831 70,526
Change in other assets and liabilities, net 0 0
Net cash provided by operating activities (6,865) (5,075)
Cash flows from investing activities:    
Capital expenditures 0 0
Acquisitions   0
Derivative settlements 0  
Derivative settlements   0
Other   0
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from Revolving Credit Facilities 0 0
Principal payments on revolving credit facility 0 0
Deferred financing costs 0 0
Purchases of treasury stock 0 0
Distributions to non-controlling interests 0 0
Investment in / capital contributions from subsidiaries 6,865 5,075
Other 0 0
Net cash provided by financing activities 6,865 5,075
Increase (decrease) in cash and cash equivalents 0 0
Beginning of period 0 0
End of period 0 0
Parent/ Issuer    
Cash flows from operating activities:    
Net income (loss) including non-controlling interests (114,882) 590
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:    
Equity in earnings (loss) of subsidiaries 89,492 (32,164)
Depreciation, depletion and amortization 0 0
Loss on sale of properties 0  
Impairment 0 0
Deferred income taxes (16,573) (8,104)
Derivative instruments 0 0
Equity-based compensation expenses 8,339 6,418
Deferred financing costs amortization and other 4,058 3,929
Working capital and other changes:    
Change in accounts receivable, net 45,831 51,714
Change in inventory 0 0
Change in prepaid expenses (130) (180)
Change in accounts payable, interest payable and accrued liabilities (11,909) (12,832)
Change in other assets and liabilities, net 0 0
Net cash provided by operating activities 4,226 9,371
Cash flows from investing activities:    
Capital expenditures 0 0
Acquisitions   0
Derivative settlements 0  
Derivative settlements   0
Other   0
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from Revolving Credit Facilities 0 0
Principal payments on revolving credit facility 0 0
Deferred financing costs 0 0
Purchases of treasury stock (4,261) (6,021)
Distributions to non-controlling interests 0 0
Investment in / capital contributions from subsidiaries 0 (3,259)
Other 0 (90)
Net cash provided by financing activities (4,261) (9,370)
Increase (decrease) in cash and cash equivalents (35) 1
Beginning of period 179 178
End of period 144 179
Combined Guarantor Subsidiaries    
Cash flows from operating activities:    
Net income (loss) including non-controlling interests (80,888) 37,035
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:    
Equity in earnings (loss) of subsidiaries (43,339) (31,529)
Depreciation, depletion and amortization 186,069 146,227
Loss on sale of properties 2,922  
Impairment 629 93
Deferred income taxes 13,026 8,932
Derivative instruments 117,611 71,116
Equity-based compensation expenses 555 273
Deferred financing costs amortization and other 2,681 1,432
Working capital and other changes:    
Change in accounts receivable, net (74,291) (23,888)
Change in inventory (3,184) (3,672)
Change in prepaid expenses 1,583 641
Change in accounts payable, interest payable and accrued liabilities 2,306 (66,000)
Change in other assets and liabilities, net (4,165) 248
Net cash provided by operating activities 121,515 140,908
Cash flows from investing activities:    
Capital expenditures (187,990) (169,994)
Acquisitions   (520,728)
Derivative settlements 13,446  
Derivative settlements   (36,974)
Other   (28)
Net cash used in investing activities (174,544) (727,724)
Cash flows from financing activities:    
Proceeds from Revolving Credit Facilities 388,000 1,413,000
Principal payments on revolving credit facility (363,000) (857,000)
Deferred financing costs 0 (215)
Purchases of treasury stock 0 0
Distributions to non-controlling interests 16,985 34,866
Investment in / capital contributions from subsidiaries 5,923 (5,986)
Other (202) 0
Net cash provided by financing activities 47,706 584,665
Increase (decrease) in cash and cash equivalents (5,323) (2,151)
Beginning of period 15,362 15,659
End of period 10,039 13,508
Combined Non-guarantor Subsidiaries    
Cash flows from operating activities:    
Net income (loss) including non-controlling interests 43,339 31,529
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:    
Equity in earnings (loss) of subsidiaries 0 0
Depreciation, depletion and amortization 8,929 6,364
Loss on sale of properties 0  
Impairment 0 0
Deferred income taxes 0 0
Derivative instruments 0 0
Equity-based compensation expenses 119 63
Deferred financing costs amortization and other 191 114
Working capital and other changes:    
Change in accounts receivable, net 208 36,992
Change in inventory 0 0
Change in prepaid expenses 52 31
Change in accounts payable, interest payable and accrued liabilities 3,438 8,062
Change in other assets and liabilities, net (226) 0
Net cash provided by operating activities 56,050 83,155
Cash flows from investing activities:    
Capital expenditures (49,458) (84,844)
Acquisitions   0
Derivative settlements 0  
Derivative settlements   0
Other   0
Net cash used in investing activities (49,458) (84,844)
Cash flows from financing activities:    
Proceeds from Revolving Credit Facilities 32,000 57,000
Principal payments on revolving credit facility (5,000) (18,000)
Deferred financing costs (43) 0
Purchases of treasury stock 0 0
Distributions to non-controlling interests (21,922) (38,316)
Investment in / capital contributions from subsidiaries (12,788) 4,170
Other (229) 0
Net cash provided by financing activities (7,982) 4,854
Increase (decrease) in cash and cash equivalents (1,390) 3,165
Beginning of period 6,649 883
End of period $ 5,259 $ 4,048